Home > Financial Ratios > AUROBINDO PHARMA

AUROBINDO PHARMA
EBIT Growth

    Back to All Ratios
AUROBINDO PHARMA is part of below Screeners ↓
Top Mid Cap Stocks with Best Fundamentals
Best Quarterly Growth Mid Cap Stocks
COMMUNITY POLL
for AUROBINDO PHARMA
Please provide your vote to see the results

AUROBINDO PHARMA Last 5 Year EBIT Growth History

[Consolidated]

Mar2025Mar2024Mar2023Mar2022Mar2021
   EBIT Growth(%) 18.2869.62-19.54-53.8883.25

What is the latest EBIT Growth ratio of AUROBINDO PHARMA ?

The latest EBIT Growth ratio of AUROBINDO PHARMA is 18.28 based on Mar2025 Consolidated results.
Year EBIT Growth
Mar202518.28
Mar202469.62
Mar2023-19.54
Mar2022-53.88
Mar202183.25

How is EBIT Growth of AUROBINDO PHARMA Trending?

Years EBIT Growth % Change
Mar2025 18.28
-73.74
Mar2024 69.62
Positive
Mar2023 -19.54
Negative
Mar2022 -53.88
Negative
Mar2021 83.25 -

Other Financial Ratios of AUROBINDO PHARMA


Compare EBIT Growth ratio of peers of AUROBINDO PHARMA

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
AUROBINDO PHARMA ₹70,671.7 Cr 2% 1.9% -2.5% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹421,131.0 Cr -0.7% -0.5% -3.1% Stock Analytics
DIVIS LABORATORIES ₹171,862.0 Cr 2.9% 1.8% 11.9% Stock Analytics
TORRENT PHARMACEUTICALS ₹129,254.0 Cr 1.5% 3.4% 12.4% Stock Analytics
CIPLA ₹121,198.0 Cr 0.2% -0.2% 0.4% Stock Analytics
DR REDDYS LABORATORIES ₹107,083.0 Cr 0.9% 4.8% -3.2% Stock Analytics


AUROBINDO PHARMA Share Price vs Sensex


Share Price Returns(%) 1 Week 1 Month 1 Year
AUROBINDO PHARMA

2%

1.9%

-2.5%

SENSEX

1%

0.3%

6.7%


You may also like the below Video Courses